CD274 and lung carcinoma: ,19 In this context, our results suggest that progressively increasing PD-L1 thresholds should be explored as predictors of immunotherapy efficacy also among patients with early stage lung cancer, to inform the design of perioperative trials with immune checkpoint blockade.